- Food Science/Microbiology
- Article
- Published:
Down-regulation of T helper 2-associated cytokine expression and selective transcription factors by fisetin
Journal of the Korean Society for Applied Biological Chemistry volume 54, pages 949–958 (2011)
Abstract
Fisetin, a flavonol, has been known as an anti-allergic agent having inhibitory effects on T helper 2 cytokine gene expression in inflammatory immune cells. However, its molecular mechanisms for suppressive effects of fisetin on interleukin (IL)-4 and IL-13 in activated mast cells and basophils have been incompletely understood. In this study we found that fisetin at the concentrations having no effect on cell viability significantly inhibited the phorbol 12-myristate 13-acetate and ionomycin induced production of IL-4 and IL-13 in bone marrow-derived mast cells and RBL-2H3 basophilic cells. The levels of mRNA were dramatically decreased by fisetin, indicating the suppression might be regulated at the transcriptional levels. Transient transfection experiments using luciferase reporter plasmids expressing IL-4 or IL-13 promoter revealed that fisetin inhibited the activation of the promoters in a dose-dependent manner. Western blot analysis of the nuclear expression of various transcription factors involved in the promoter activation indicated that suppressions of c- Fos and CCAAT/enhancer-binding protein alpha were prominent together with significant downregulations of nuclear factor of activated T cell (NF-AT) and NF-κB. Furthermore, nuclear expression of GATA-1 and GATA-2, and the mRNA expression were significantly down regulated by fisetin, whereas cyclosporine A had no significant effects on GATA transcription factors. Taken together, fisetin has suppressive effects on IL-4 and IL-13 gene expressions through the regulation of selective transcription factors.
References
Choi JJ, Park BK, Park S, Yun CY, Kim DH, Kim JS, Hwang ES, and Jin M (2009) Development of an in vitro test system measuring transcriptional downregulatory activities on IL-13. J Microbiol Biotechnol 19, 331–337.
Choi JJ, Park BK, Song GY, Kim JS, Kim JH, Kim DH, and Jin M (2007) Establishment of an in vitro test system to evaluate the down-regulatory activities of natural products on IL-4. Arch Pharm Res 30, 1102–1110.
Garcia V, Arts IC, Sterne JA, Thompson RL, and Shaheen SO (2005) Dietary intake of flavonoids and asthma in adults. Eur Respir J 26, 449–452.
Gilfillan AM and Tkaczyk C (2006) Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 6, 218–230.
Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, and Leung DY (1996) In vivo expression of IL-12 and IL- 13 in atopic dermatitis. J Allergy Clin Immunol 98, 225–231.
Henkel G and Brown MA (1994) PU.1 and GATA: Components of a mast cell-specific interleukin 4 intronic enhancer. Proc Natl Acad Sci USA 91, 7737–7741.
Hernandez-Hernandez A, Ray P, Litos G, Ciro M, Ottolenghi S, Beug H, and Boyes J (2006) Acetylation and MAPK phosphorylation cooperate to regulate the degradation of active GATA-1. EMBO J 25, 3264–3274.
Higa S, Hirano T, Kotani M, Matsumoto M, Fujita A, Suemura M, Kawase I, and Tanaka T (2003) Fisetin, a flavonol, inhibits TH2-type cytokine production by activated human basophils. J Allergy Clin Immunol 111, 1299–1306.
Hural JA, Kwan M, Henkel G, Hock MB, and Brown MA (2000) An intron transcriptional enhancer element regulates IL-4 gene locus accessibility in mast cells. J Immunol 165, 3239–3249.
Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Tertilt C, Bopp T, Heib V, Becker M, Taube C, Schild H, Schmitt E, and Stassen M (2006) Specific and redundant roles for NFAT transcription factors in the expression of mast cellderived cytokines. J Immunol 177, 6667–6674.
Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, and Aromaa A (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76, 560–568.
Kotani M, Matsumoto M, Fujita A, Higa S, Wang W, Suemura M, Kishimoto T, and Tanaka T (2000) Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J Allergy Clin Immunol 106, 159–166.
Kwan M, Powell DR, Nachman TY, and Brown MA (2005) An intron GATA-binding site regulates chromatin accessibility and is essential for IL-4 gene expression in mast cells. Eur J Immunol 35, 1267–1274.
Letting DL, Rakowski C, Weiss MJ, and Blobel GA (2003) Formation of a tissue-specific histone acetylation pattern by the hematopoietic transcription factor GATA-1. Mol Cell Biol 23, 1334–1340.
Lorentz A, Klopp I, Gebhardt T, Manns MP, and Bischoff SC (2003) Role of activator protein 1, nuclear factor-kappaB, and nuclear factor of activated T cells in IgE receptormediated cytokine expression in mature human mast cells. J Allergy Clin Immunol 111, 1062–1068.
Masuda A, Hashimoto K, Yokoi T, Doi T, Kodama T, Kume H, Ohno K, and Matsuguchi T (2007) Essential role of GATA transcriptional factors in the activation of mast cells. J Immunol 178, 360–368.
Masuda A, Yoshikai Y, Kume H, and Matsuguchi T (2004) The interaction between GATA proteins and activator protein-1 promotes the transcription of IL-13 in mast cells. J Immunol 173, 5564–5573.
Migliaccio AR, Rana RA, Sanchez M, Lorenzini R, Centurione L, Bianchi L, Vannucchi AM, Migliaccio G, and Orkin SH (2003) GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J Exp Med 197, 281–296.
Monticelli S, Solymar DC, and Rao A (2004) Role of NFAT proteins in IL13 gene transcription in mast cells. J Biol Chem 279, 36210–36218.
Oh K, Shen T, Le Gros G, and Min B (2007) Induction of Th2 type immunity in a mouse system reveals a novel immunoregulatory role of basophils. Blood 109, 2921–2927.
Ozawa Y, Towatari M, Tsuzuki S, Hayakawa F, Maeda T, Miyata Y, Tanimoto M, and Saito H (2001) Histone deacetylase 3 associates with and represses the transcription factor GATA-2. Blood 98, 2116–2123.
Park HH, Lee S, Oh JM, Lee MS, Yoon KH, Park BH, Kim JW, Song H, and Kim SH (2007) Anti-inflammatory activity of fisetin in human mast cells (HMC-1). Pharmacol Res 55, 31–37.
Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D’Agati V, Orkin SH, and Costantini F (1991) Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349, 257–260.
Qi X, Nishida J, Chaves L, Ohmori K, and Huang H (2011) CCAAT/enhancer-binding protein alpha (C/EBPalpha) is critical for interleukin-4 expression in response to FcepsilonRI receptor cross-linking. J Biol Chem 286, 16063–16073.
Rivera J and Gilfillan AM (2006) Molecular regulation of mast cell activation. J Allergy Clin Immunol 117, 1214–1225; quiz 1226.
Sung B, Pandey MK, and Aggarwal BB (2007) Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting proteinregulated IkappaBalpha kinase activation. Mol Pharmacol 71, 1703–1714.
Weiss DL, Hural J, Tara D, Timmerman LA, Henkel G, and Brown MA (1996) Nuclear factor of activated T cells is associated with a mast cell interleukin 4 transcription complex. Mol Cell Biol 16, 228–235.
Wills-Karp M and Chiaramonte M (2003) Interleukin-13 in asthma. Curr Opin Pulm Med 9, 21–27.
Yamashita K, Gon Y, Shimokawa T, Nunomura S, Endo D, Miyata N, Hashimoto S, Van Lint J, and Ra C (2010) High affinity receptor for IgE stimulation activates protein kinase D augmenting activator protein-1 activity for cytokine producing in mast cells. Int Immunopharmacol 10, 277–283.
Author information
Authors and Affiliations
Corresponding author
Additional information
M. Jin and S. J. Yoon contributed equally.
Rights and permissions
About this article
Cite this article
Jin, M., Yoon, S.J. & Pyo, M.Y. Down-regulation of T helper 2-associated cytokine expression and selective transcription factors by fisetin. J Korean Soc Appl Biol Chem 54, 949–958 (2011). https://doi.org/10.1007/BF03253185
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03253185